Table 3.
Fixed and fitted input parameters for the PBPK model, showing compound-specific parameter differences between [68Ga]Ga-DOTATATE and [68Ga]Ga-HA-DOTATATE, and system-specific parameter differences between the tumor compartments
| Parameter | Fixed or fitted (*) value [range used in predictions] | |
|---|---|---|
| Compound-specific | [68Ga]Ga-DOTATATE | [68Ga]Ga-HA-DOTATATE |
| Molecular weight | 1502.3 g/mol | 1628.5 g/mol |
| Lipophilicity | − 3.69 | − 3.12 |
| KD | 0.20 nmol/L | 0.23 nmol/L * |
| koff | 0.012 min−1 | 0.0071 min−1 * |
| kint | 0.161 min−1 | 0.268 min−1 |
| kdeg | 0.00012 min−1 | 0.00012 min−1 |
| Fraction unbound | 0.69 | 0.69 |
| System-specific | Primary tumor | Liver metastases | Other metastases |
|---|---|---|---|
| Fraction vascular | 0.21 [0.09–0.34] | 0.17 [0.1–0.23] | 0.075 [0.025–0.125] |
| Fraction interstitial | 0.3 | 0.3 | 0.3 |
| Blood flow | 152 mL/min/100 g [53–252] | 203 mL/min/100 g [139–363] | 152 mL/min/100 g [53–252] |
| SSTR concentration (interstitial) | 168 nmol/L | 224 nmol/L | 224 nmol/L |
KD Equilibrium dissociation constant; koff Dissociation rate constant; kint Internalization rate; kdeg Degradation rate; SSTR Somatostatin receptor